Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Strengths Most developed behavior change platform, refined over 15+ years Integrated medication and behavioral approach may produce better long-term outcomes Brand-name Wegovy available with insurance facilitation Large existing user base and brand recognition Dual-track support (clinical and behavioral coaching) Extensive educational content and daily engagement through the app Considerations Highest starting price among the providers reviewed ($249/month) The behavioral platform is bundled and may not appeal to all patients Uses a mix of 503A and 503B pharmacies Some patients report the Noom app experience can feel repetitive or overly simplistic Integration between the clinical and behavioral tracks could be stronger The value proposition is weaker for patients who only want medication access Best For Patients who believe strongly in the value of structured behavior change alongside medication and want an all-in-one platform that addresses both
Seek Professional Guidance: Working with a nutritionist or a medical professional can be a huge benefit
The REWIND trial was noteworthy as, from its total of 9,901 participants, the majority (68.5%) had CV risk factors only at baseline and fewer than one-third (31.5%) had established CVD
Some people use single-dose pens, while others use vials or the Zepbound QuikPen through programs like LillyDirect
US$ 25.49
US$ 29.75
US$ 27.78
US$ 27.53
US$ 27.48
US$ 27.07
US$ 20.89
US$ 25.51
US$ 21.05
US$ 28.55
